Literature DB >> 16434653

Analgesic overuse among adolescents with headache: the Head-HUNT-Youth Study.

Grete Dyb1, Turid Lingaas Holmen, John-Anker Zwart.   

Abstract

OBJECTIVES: To examine the association between the use of analgesics and primary headache disorders (i.e., migraine and tension-type headache) among adolescents in relation to age, gender, and headache frequency.
METHODS: This cross-sectional, population-based study was conducted in Norway from 1995 to 1997. The total study population consisted of 5,471 adolescents, 13 to 18 years of age, who were interviewed about their headache complaints and completed a comprehensive questionnaire including use of analgesics.
RESULTS: The prevalence of daily headache associated with analgesic use was 0.5%, with a higher rate for girls (0.8%) than for boys (0.2%). There was a significant association for both genders between analgesic use and headache, although most pronounced for migraine. There was a significant linear relationship between analgesic use and headache frequency. Analgesic use was more common among girls than boys and increased with age both for those with and those without headache.
CONCLUSIONS: The use of analgesics is common among adolescents with headache, especially among girls. Although this study did not directly evaluate for medication-overuse headache, the trend of frequent analgesic use suggests this possibility. Parents and physicians should increase their awareness of potential analgesic overuse, especially among adolescents with frequent headache.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16434653     DOI: 10.1212/01.wnl.0000193630.03650.19

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  26 in total

Review 1.  Medication overuse headache.

Authors:  Valerie Cheung; Farnaz Amoozegar; Esma Dilli
Journal:  Curr Neurol Neurosci Rep       Date:  2015-01       Impact factor: 5.081

Review 2.  Headache in school children: prevalence and risk factors.

Authors:  Andreas Straube; Florian Heinen; Friedrich Ebinger; Rüdiger von Kries
Journal:  Dtsch Arztebl Int       Date:  2013-11-29       Impact factor: 5.594

Review 3.  Medication-overuse headache: epidemiology, diagnosis and treatment.

Authors:  Espen Saxhaug Kristoffersen; Christofer Lundqvist
Journal:  Ther Adv Drug Saf       Date:  2014-04

Review 4.  Pathophysiology of medication overuse headache: insights and hypotheses from preclinical studies.

Authors:  Ian D Meng; David Dodick; Michael H Ossipov; Frank Porreca
Journal:  Cephalalgia       Date:  2011-03-28       Impact factor: 6.292

5.  Stress and use of over-the-counter analgesics: prevalence and association among Danish 25 to 44-year-olds from 1994 to 2005.

Authors:  Vibeke Koushede; Ola Ekholm; Bjørn E Holstein; Anette Andersen; Ebba Holme Hansen
Journal:  Int J Public Health       Date:  2010-09-01       Impact factor: 3.380

6.  Headache and migraine in children with sickle cell disease are associated with lower hemoglobin and higher pain event rates but not silent cerebral infarction.

Authors:  Michael M Dowling; Michael J Noetzel; Mark J Rodeghier; Charles T Quinn; Deborah G Hirtz; Rebecca N Ichord; Janet L Kwiatkowski; E Steven Roach; Fenella J Kirkham; James F Casella; Michael R DeBaun
Journal:  J Pediatr       Date:  2014-02-13       Impact factor: 4.406

Review 7.  Medication overuse headache in children and adolescents.

Authors:  Matteo Chiappedi; Umberto Balottin
Journal:  Curr Pain Headache Rep       Date:  2014-04

Review 8.  Prevalence of headache in Europe: a review for the Eurolight project.

Authors:  Lars Jacob Stovner; Colette Andree
Journal:  J Headache Pain       Date:  2010-05-16       Impact factor: 7.277

Review 9.  Adolescent issues in migraine: a focus on menstrual migraine.

Authors:  Christine L Lay; Susan W Broner
Journal:  Curr Pain Headache Rep       Date:  2008-10

Review 10.  Medication-overuse headache: risk factors, pathophysiology and management.

Authors:  Hans-Christoph Diener; Dagny Holle; Kasja Solbach; Charly Gaul
Journal:  Nat Rev Neurol       Date:  2016-09-12       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.